Skip to main content
. 2023 Aug 3;13:12580. doi: 10.1038/s41598-023-39781-4

Table 1.

Baseline characteristics of enrolled geriatric ischemic stroke patients.

Characteristics All patients (n = 1259) Development dataset (n = 894) Validation dataset (n = 365) P-value
Age, median (IQR) 76.83 (70.93, 82.82) 77.00 (71.13, 82.67) 76.30 (70.12, 83.14) 0.732
Female, No. (%) 659 (52.34) 465 (52.01) 194 (53.15) 0.714
Weight, median (IQR) (kg) 76.00 (64.30, 89.20) 76.30 (65.00, 88.50) 75.30 (63.60, 90.60) 0.963
Marital status, No. (%)
 Married 551 (43.76) 397 (44.41) 154 (42.19) 0.385
 Single 227 (18.03) 166 (18.57) 61 (16.71)
 Other 481 (38.20) 331 (37.02) 150 (41.10)
First care unit, No. (%)
 Medical ICU 112 (8.90) 74 (8.28) 38 (10.41) 0.325
 Surgical ICU 396 (31.45) 284 (31.77) 112 (30.68)
 Medical ICU/Surgical ICU 59 (4.69) 41 (4.59) 18 (4.93)
 Neuro surgical ICU 172 (13.66) 113 (12.64) 59 (16.16)
 Trauma surgical ICU 128 (10.17) 97 (10.85) 31 (8.49)
 Other ICU 392 (31.14) 285 (31.88) 107 (29.32)
Underlying diseases, No. (%)
 Myocardial infarct 225 (17.87) 151 (16.89) 74 (20.27) 0.155
 Congestive heart failure 339 (26.93) 237 (26.51) 102 (27.95) 0.602
 Chronic pulmonary disease 251 (19.94) 178 (19.91) 73 (20.00) 0.971
 Rheumatic disease 45 (3.57) 34 (3.80) 11 (3.01) 0.494
 Peptic ulcer disease 23 (1.83) 15 (1.68) 8 (2.19) 0.537
 Liver disease 51 (4.05) 39 (4.36) 12 (3.29) 0.380
 Renal disease 237 (18.82) 173 (19.35) 64 (17.53) 0.454
 Diabetes 468 (37.17) 338 (37.81) 130 (35.62) 0.465
 Paraplegia 627 (49.80) 443 (49.55) 184 (50.41) 0.782
 Metastatic solid tumor 44 (3.49) 29 (3.24) 15 (4.11) 0.448
 CCI, median (IQR) 8.00 (6.00, 9.00) 8.00 (6.00, 9.00) 8.00 (7.00, 9.00) 0.582
Disease severity score, median (IQR)
 Firstday SOFA 4.00 (2.00, 6.00) 4.00 (2.00, 6.00) 4.00 (2.00, 6.00) 0.986
 Firstday LODS 4.00 (2.00, 7.00) 4.00 (2.00, 7.00) 4.00 (2.00, 7.00) 0.725
 Firstday OASIS 34.00 (28.00, 41.00) 34.00 (28.00, 41.00) 34.00 (28.00, 41.00) 0.772
 Firstday APS III 44.00 (32.00, 61.00) 43.00 (32.00, 60.00) 45.00 (32.00, 62.00) 0.809
 Firstday SAPS II 35.00 (29.00, 44.00) 35.00 (29.00, 44.00) 36.00 (29.00, 43.00) 0.788
Vital indicators, median (IQR)
 Temperature (°C)** 36.88 (36.66, 37.13) 36.89 (36.67, 37.14) 36.85 (36.66, 37.12) 0.396
 Heart rate (beats/min)** 79.64 (70.15, 90.11) 79.84 (70.27, 90.52) 78.26 (69.92, 88.77) 0.399
 Respiratory rate (breaths/min)** 18.79 (16.87, 20.93) 18.80 (16.96, 20.86) 18.76 (16.79, 21.25) 0.873
 SBP (mmHg)** 131.87 (118.88, 145.22) 132.42 (119.50, 145.27) 130.47 (117.70, 145.03) 0.368
 Oxygen saturation (%)** 97.23 (95.92, 98.50) 97.24 (95.85, 98.50) 97.23 (96.12, 98.48) 0.543
 Firstday GCS* 11.00 (8.00, 14.00) 11.00 (8.00, 14.00) 12.00 (8.00, 14.00) 0.784
 Glucose (mmol/L)** 7.30 (6.15, 8.97) 7.25 (6.11, 8.84) 7.43 (6.27, 9.32) 0.185
 Firstday urine output (L) 1.44 (0.94, 2.11) 1.46 (0.95, 2.10) 1.40 (0.93, 2.13) 0.715
Laboratory indicators, median (IQR)
 White blood cells (K/uL)*** 11.40 (8.70, 15.40) 11.20 (8.60, 15.30) 11.70 (9.10, 15.40) 0.179
 Platelets (K/uL)*** 215.00 (169.00, 272.00) 213.50 (172.00, 269.00) 217.00 (164.00, 276.00) 0.928
 Blood urea nitrogen (mg/dL)*** 7.50 (5.36, 10.35) 7.44 (5.36, 10.35) 7.50 (5.71, 10.35) 0.477
 Creatinine (μmmol/L)*** 88.40 (70.72, 123.76) 88.40 (70.72, 123.76) 88.40 (70.72, 114.92) 0.588
 Sodium (mEq/L)*** 140.60 (138.00, 143.00) 141.00 (138.00, 143.00) 140.00 (138.00, 143.00) 0.233
 Potassium (mEq/L)*** 4.30 (3.90, 4.70) 4.30 (3.90, 4.70) 4.30 (3.90, 4.70) 0.649
 Prothrombin time (sec)*** 13.30 (12.00, 15.50) 13.30 (12.00, 15.50) 13.30 (11.90, 15.50) 0.887
 International normalized ratio*** 1.20 (1.10, 1.40) 1.20 (1.10, 1.40) 1.20 (1.10, 1.40) 0.869
 Anion gap (mmol/L)*** 16.00 (14.00, 18.00) 16.00 (14.00, 18.00) 16.00 (14.00, 18.00) 0.858
Intervention measures, No. (%)
 Endovascular obstruction removal 118 (9.37) 78 (8.72) 40 (10.96) 0.217
 Alteplase 25 (1.99) 15 (1.68) 10 (2.74) 0.220
Antiplatelet 338 (26.85) 245 (27.40) 93 (25.48) 0.484
 Heparin 375 (29.79) 268 (29.98) 107 (29.32) 0.816
 Mannitol 34 (2.70) 24 (2.68) 10 (2.74) 0.956
 Vasoactive agent 302 (23.99) 212 (23.71) 90 (24.66) 0.722
 Invasive mechanical ventilation 436 (34.63) 305 (34.12) 131 (35.89) 0.548
 Intracranial pressure monitor 34 (2.70) 26 (2.91) 8 (2.19) 0.477
Outcomes
 28-Day mortality (%) 332 (26.37) 237 (26.51) 95 (26.03) 0.860
 ICU mortality (%) 186 (14.77) 130 (14.54) 56 (15.34) 0.716
 Hospital mortality (%) 267 (21.21) 186 (20.81) 81 (22.19) 0.585
 ICU LOS (days) 3.31 (1.94, 6.98) 3.21 (1.92, 6.88) 3.61 (2.00, 7.31) 0.423
 Hospital LOS (days) 8.53 (4.93, 16.70) 8.74 (4.94, 16.65) 8.29 (4.93, 16.81) 0.883

The term "antiplatelet" was operationally defined as the administration of aspirin, clopidogrel, or dipyridamole within the first 24 h following admission to the ICU. Similarly, the term "vasoactive agent" was operationally defined as the administration of norepinephrine, epinephrine, phenylephrine, dopamine, dobutamine, vasopressin, or milrinone within the first 24 h following ICU admission. Within this same timeframe, assessments were conducted on disease severity scores, vital indicators, laboratory indicators, and interventions.

CCI Charlson Comorbidity Index, ICU Intensive Care Unit, IQR Interquartile Range; GCS Glasgow Coma Scale, APS III Acute Physiology Score III, SOFA Sequential Organ Failure Assessment, LODS Logistic Organ Dysfunction System, SAPS II Simplified Acute Physiology Score II, OASIS Oxford Acute Severity of Illness Score, SBP Systolic Blood Pressure, LOS Length of Stay.

*The minimum value of indicators on the firstday of ICU stay.

**The mean value of indicators on the firstday of ICU stay.

***The maximum value of indicators on the firstday of ICU stay.